Rafferty Asset Management, LLC Cytokinetics Inc Transaction History

Rafferty Asset Management, LLC

$28.9 Billion
Q3 2024

A detailed history of Rafferty Asset Management, LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 216,826 shares of CYTK stock, worth $10.8 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

216,826

Previous 265,069 18.2%

Holding current value

$10.8 Million

Previous $14.4 Million 20.28%

% of portfolio

0.04%

Previous 0.05%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$51.22 - $60.16 $2.47 Million - $2.9 Million	-48,243 Reduced 18.2%	216,826 $11.4 Million
Q2 2024 Aug 13, 2024	BUY	$47.86 - $75.05 $6.01 Million - $9.43 Million	125,592 Added 90.04%	265,069 $14.4 Million
Q1 2024 May 13, 2024	SELL	$63.75 - $108.06 $7.89 Million - $13.4 Million	-123,798 Reduced 47.02%	139,477 $9.78 Million
Q4 2023 Feb 13, 2024	BUY	$26.88 - $83.49 $439,568 - $1.37 Million	16,353 Added 6.62%	263,275 $22 Million
Q3 2023 Nov 13, 2023	BUY	$29.46 - $36.61 $662,791 - $823,651	22,498 Added 10.02%	246,922 $7.27 Million
Q2 2023 Aug 11, 2023	BUY	$32.62 - $40.75 $1.09 Million - $1.36 Million	33,270 Added 17.4%	224,424 $7.32 Million
Q1 2023 May 11, 2023	SELL	$33.36 - $45.71 $1.14 Million - $1.56 Million	-34,223 Reduced 15.18%	191,154 $6.73 Million
Q4 2022 Feb 13, 2023	BUY	$35.77 - $51.11 $3.52 Million - $5.02 Million	98,277 Added 77.32%	225,377 $10.3 Million
Q3 2022 Nov 14, 2022	BUY	$38.54 - $54.52 $1.17 Million - $1.66 Million	30,443 Added 31.5%	127,100 $6.16 Million
Q2 2022 Aug 12, 2022	SELL	$33.93 - $48.92 $1.56 Million - $2.25 Million	-45,945 Reduced 32.22%	96,657 $3.8 Million
Q1 2022 May 13, 2022	SELL	$29.74 - $46.0 $103,078 - $159,436	-3,466 Reduced 2.37%	142,602 $5.25 Million
Q4 2021 Feb 10, 2022	BUY	$34.35 - $46.38 $1.39 Million - $1.88 Million	40,511 Added 38.38%	146,068 $6.66 Million
Q3 2021 Nov 10, 2021	SELL	$18.54 - $35.74 $341,580 - $658,473	-18,424 Reduced 14.86%	105,557 $3.77 Million
Q2 2021 Aug 10, 2021	SELL	$19.79 - $26.99 $435,775 - $594,319	-22,020 Reduced 15.08%	123,981 $2.45 Million
Q1 2021 May 10, 2021	BUY	$18.57 - $25.68 $1.97 Million - $2.73 Million	106,276 Added 267.53%	146,001 $3.4 Million
Q4 2020 Feb 10, 2021	SELL	$15.26 - $28.61 $479,041 - $898,125	-31,392 Reduced 44.14%	39,725 $825,000
Q3 2020 Nov 13, 2020	BUY	$20.58 - $28.96 $1.02 Million - $1.43 Million	49,344 Added 226.63%	71,117 $1.54 Million
Q2 2020 Aug 07, 2020	BUY	$11.15 - $24.64 $242,768 - $536,486	21,773 New	21,773 $513,000
Q1 2020 May 15, 2020	SELL	$8.75 - $16.3 $419,965 - $782,334	-47,996 Closed	0 $0
Q4 2019 Feb 10, 2020	SELL	$7.95 - $11.84 $195,951 - $291,832	-24,648 Reduced 33.93%	47,996 $509,000
Q3 2019 Nov 14, 2019	SELL	$10.82 - $14.25 $8,515 - $11,214	-787 Reduced 1.07%	72,644 $827,000
Q2 2019 Aug 09, 2019	BUY	$7.95 - $11.25 $196,206 - $277,650	24,680 Added 50.62%	73,431 $826,000
Q1 2019 May 15, 2019	BUY	$5.95 - $10.19 $290,068 - $496,772	48,751 New	48,751 $394,000

Others Institutions Holding CYTK

# of Institutions

406

Shares Held

125M

Call Options Held

4.61M

Put Options Held

2.46M

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.7B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Account

Rafferty Asset Management, LLC Cytokinetics Inc Transaction History